Stocks from pharmaceutical companies and healthcare spaces dominated analysts' choices for Thursday's trading session.

Migraine is recognized globally as the seventh most disabling condition across all diseases, accounting for approximately 2.9% of all years lived with disability (YLDs). It is also the top cause of ...

Turning thet tide against tuberculosis . As the world's deadliest infectious disease surges, GSK and partners are pioneering ...

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The risk of mortality among older adults hospitalized with influenza was significantly lower among those who received oseltamivir vs no antiviral therapy.